Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

CDC Links Zika Virus to Microcephaly, Other Birth Defects

The Centers for Disease Control and Prevention (CDC) announced that Zika virus is a cause of microcephaly and other serious fetal brain abnormalities. The conclusion follows an extensive evaluation of available scientific data.

05/01/2026 · Alabama edition

Advertisement

Advertisement

Why it matters locally: The Alabama Department of Public Health will likely update its guidelines for pregnant women and those planning to become pregnant, based on this new determination from the CDC. Alabama residents should consult with their healthcare providers for specific advice and information regarding Zika virus prevention and testing.

Atlanta — The Centers for Disease Control and Prevention (CDC) has determined that the Zika virus causes microcephaly and other severe brain defects in developing fetuses. The agency announced its conclusion following a comprehensive review of existing scientific evidence. According to the CDC, the determination marks a shift in scientific understanding of the virus. Previously, the Zika virus was suspected of having a connection to these conditions, but now the CDC asserts a definitive causal relationship. Microcephaly is a condition where a baby's head is significantly smaller than expected, often indicating incomplete brain development. The agency noted that the link extends to "other severe fetal brain defects", without elaborating on specific examples. CDC officials did not specify the precise data or studies that led to the agency's determination in the released statement. Additional information is expected to be released outlining the evidentiary basis for the conclusion.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Alabama

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Alabama

health

Government Review Examines Diagnoses of ADHD and Autism in Young People

A recent government review focused on younger individuals and their diagnoses of ADHD and autism. The report highlighted a shift in diagnostic patterns over time. Officials involved in the review acknowledged evolving societal and clinical approaches.

Read Story →
health

Discussion Addresses Mental Health, Suicide Trends in Black Community

NPR's Michel Martin hosted a panel discussion on mental health and suicide within the Black community. The conversation explored the subject through personal perspectives. Participants shared individual experiences.

Read Story →
health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
health

Report Examines Impact of Trump Administration's Drug Pricing Initiatives

A recent report evaluated the Trump administration's claims regarding drug prices, including the effectiveness of TrumpRx discounts. Findings indicate a mixed impact on prescription drug costs for consumers. The administration has asserted that the U.S. now pays the world's lowest drug prices.

Read Story →
health

Cost of GLP-1 Medications Prompts Search for Alternatives

Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.

Read Story →
Scroll for more stories